Business Standard

Dr Reddy's Laboratories receives tentative approval for Zenavod (doxycycline) Capsules

Image

Capital Market

From US FDA

Dr Reddy's Laboratories announced that the United States Food and Drug Adminstration tentative approval for Zenavod (doxycycline) Capsules, 40 mg. Zenavod is a tetracycline-class drug indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. Promius Pharma, LLC, the US subsidiary of Dr Reddy's Laboratories will be responsible for commercialising Zenavod in the US market.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 01 2016 | 12:09 PM IST

Explore News